![.](tbl_spacer.png) 0 Table of Contents |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 1 Home |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 2 Changelog |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 3 Document Dis |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 4 Document Mtp |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 5 Document Padv |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 6 Document Pml |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 7 Document Pmlc |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 8 Document Pre |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 9 Guidance Amount Quantity |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 10 Guidance Compositions |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 11 Guidance Datatypes |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 12 Guidance Index |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 13 Guidance Others |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 14 Guidance Treatment |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 15 Use Case |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 16 Workflow |
![.](tbl_spacer.png) ![.](tbl_vjoin_end-open.png) 17 Artifacts Summary |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.1 Body Weight Observation |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.2 CH EMED EPR Device |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.3 CH EMED EPR Medication |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.4 CH EMED EPR Medication (DIS) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.5 CH EMED EPR Organization |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.6 CH EMED EPR Patient |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.7 CH EMED EPR Practitioner |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.8 CH EMED EPR PractitionerRole |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.9 CH EMED EPR RelatedPerson |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.10 DIS Composition |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.11 DIS Document |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.12 DIS MedicationDispense |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.13 MTP Composition |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.14 MTP Document |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.15 MTP MedicationStatement |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.16 PADV Changed MedicationRequest |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.17 PADV Changed MedicationStatement |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.18 PADV Composition |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.19 PADV Document |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.20 PADV Observation |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.21 PML Composition |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.22 PML Document |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.23 PML MedicationDispense |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.24 PML MedicationRequest |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.25 PML MedicationStatement |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.26 PML Observation |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.27 PMLC Composition |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.28 PMLC Document |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.29 PMLC MedicationStatement |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.30 PRE Composition |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.31 PRE Document |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.32 PRE MedicationRequest |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.33 Amount Quantity |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.34 Amount Range |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.35 Dosage (MedicationRequest) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.36 Dosage (MedicationStatement / MedicationDispense) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.37 Dosage Split |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.38 Ratio (Amount / Amount) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.39 Ratio (Amount / Time) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.40 Time Quantity |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.41 Amount Quantity Unit Codes |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.42 Event Timings |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.43 Route of Administration |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.44 Substance Administration Substitution Codes |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.45 Time Quantity Unit Codes |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.46 Bundle: DIS 1 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.47 Bundle: MTP 1 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.48 Bundle: MTP Dafalgan Effervescent CARAPMP004 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.49 Bundle: MTP Paracetamol CARAPMP004 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.50 Bundle: PADV 1 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.51 Bundle: PADV 2 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.52 Bundle: PADV CANCEL paracetamol Axapharm |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.53 Bundle: PML #1 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.54 Bundle: PMLC document with a prescribed axapharm paracetamol treatment |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.55 Bundle: PMLC document with a prescribed dafalgan effervescent paracetamol treatment |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.56 Bundle: PMLC #1 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.57 Bundle: PRE 1 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.58 Bundle: PRE Dafalgan eff 500mg |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.59 Bundle: PRE Paracetamol Axapharm 1g |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.60 Bundle: use case PML #1 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.61 Changed Medication Statement: Triatec (PADV) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.62 Composition for PMLC document with a prescribed dafalgan effervescent paracetamol treatment |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.63 Composition: PMLC document with a prescribed axapharm paracetamol treatment |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.64 Composition: use case PML #1 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.65 Device: PMP Aggregator |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.66 Medication: Triatec |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.67 MedicationDispense: Triatec (DIS) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.68 MedicationDispense: Triatec (PML) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.69 MedicationNorvasc |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.70 MedicationParacetamolAxapharm |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.71 MedicationParacetamolDafalganEff |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.72 MedicationRamipril |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.73 MedicationRequest: Dafalgan effervescent 500mg (PRE) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.74 MedicationRequest: Paracetamol Axapharm 1g (PRE) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.75 MedicationRequest: Triatec (PML) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.76 MedicationRequest: Triatec (PRE) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.77 MedicationStatement: Paracetamol Axapharm (MTP) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.78 MedicationStatement: Paracetamol Axapharm (PMLC) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.79 MedicationStatement: Paracetamol Dafalgan Effervescent (MTP) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.80 MedicationStatement: Paracetamol Dafalgan Effervescent (MTP) with split dose |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.81 MedicationStatement: Paracetamol Dafalgan Effervescent (PMLC) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.82 MedicationStatement: Triatec (MTP) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.83 MedicationWithATC |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.84 MedicationWithTwoIngredients |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.85 Observation: CANCEL of Axapharm paracetamol treatment. |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.86 Observation: Ramipril (PADV) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.87 Observation: Triatec (PADV) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.88 Observation: Triatec (PML) |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.89 Organization: CARA |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.90 Organization: HUG |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.91 Patient: Dupont |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.92 Patient: Michaël Christopher KARCE |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 17.93 Practitioner: Perry Cox |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin_end.png) 17.94 PractitionerRole: Perry Cox @ HUG |